Lotan, Y. Et Al. 2018. Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer.. BJU international , vol.122, no.3 , 434-440.

Lotan, Y., Woldu, S. L., Sanli, O., Black, P., & Milowsky, M. I., (2018). Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer.. BJU international , vol.122, no.3, 434-440.

Lotan, Yair Et Al. "Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer.," BJU international , vol.122, no.3, 434-440, 2018

Lotan, Yair Et Al. "Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer.." BJU international , vol.122, no.3, pp.434-440, 2018

Lotan, Y. Et Al. (2018) . "Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer.." BJU international , vol.122, no.3, pp.434-440.

@article{article, author={Yair Lotan Et Al. }, title={Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer.}, journal={BJU international}, year=2018, pages={434-440} }